RA Capital Management »

Immatics shares owned by RA Capital Management

Quarter-by-quarter ownership of Immatics (IMTX) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Immatics

Tip: Access up to 7 years of quarterly data

All positions including Immatics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immatics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 1.8M 10.51

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Janux Therapeutics SH (JANX)
Aerovate Therapeutics SH (AVTE)
Rhythm Pharmaceuticals SH (RYTM)
Evolent Health Inc - A SH (EVH)
Newamsterdam Pharma Co Nv SH (NAMS)
Rxsight SH (RXST)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
4d Molecular Therapeutics In SH (FDMT)
Biogen SH (BIIB)
Pepgen SH (PEPG)
Geron Corp SH (GERN)

View all positions for RA Capital Management

Top funds holding Immatics

Rtw Investments
Wellington Management Company
Baker Bros. Advisors
T. Rowe Price Investment Management
Perceptive Advisors
T. Rowe Price Associates
Paradigm Biocapital Advisors
Woodline Partners
Sofinnova Ventures
Goldman Sachs Group
OrbiMed Advisors
RA Capital Management
VR Adviser
Logos Global Management
Suvretta Capital Management

View all funds holding Immatics